Business
Former Moderna Chief Development Officer Melanie Ivarsson OBE Joins PhaseV's Scientific Advisory Board
PhaseV, a leader in AI/ML-driven clinical development, today announced the appointment of Melanie Ivarsson OBE, PhD, to the company's scientific advisory board. A veteran drug development leader, Dr. Ivarsson most recently served as Senior Vice President and Chief Development Officer at Moderna, where she was honored as an Officer of the Order of the British Empire (OBE) for her leadership in the development of one of the first COVID-19 vaccinations.
About this update from Moderna, Inc.
[{"type":"text","content":"Veteran Global Clinical Leader, Honored for Helping Develop One of the First COVID Vaccines, to Support Rollout of PhaseV's New AI Platform for Clinical Development","length":168,"tagName":"p","attribs":{}},{"type":"text","content":"BOSTON, July 1, 2025 /PRNewswire/ -- PhaseV, a leader in AI/ML-driven clinical development, today announced the appointment of Melanie Ivarsson OBE, PhD, to the company's scientific advisory board. A veteran drug development leader, Dr. Ivarsson most recently served as Senior Vice President and Chief Development Officer at Moderna, where she was honored as an Officer of the Order of the British Empire (OBE) for her leadership in the development of one of the first COVID-19 vaccinations.","length":500,"tagName":"p"},{"type":"image","alt":"Melanie Ivarsson OBE appointed to PhaseV’s scientific advisory board","displaySize":"","headline":null,"caption":"Melanie Ivarsson OBE appointed to PhaseV’s scientific advisory board","className":"","disableSlideshowImg":false,"size":{"original":{"width":320,"height":400,"url":"https://media.zenfs.com/en/prnewswire.com/4647f0c0b1ab31e8d36ba224612c050a"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/40SUrJJ6QPyLcj3RDuft6g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTY0MDtoPTgwMDtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/4647f0c0b1ab31e8d36ba224612c050a","width":320,"height":400},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/40SUrJJ6QPyLcj3RDuft6g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTY0MDtoPTgwMDtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/4647f0c0b1ab31e8d36ba224612c050a","width":320,"height":400}},"href":"https://mma.prnewswire.com/media/2722727/Melanie_Ivarsson_OBE_PhaseV.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"Dr. Ivarsson's appointment coincides with the launch of PhaseV's new ClinOps platform, a next-generation AI solution to optimize clinical trial operations through enhanced site selection and performance monitoring.","length":222,"tagName":"p"},{"type":"text","content":""PhaseV's groundbreaking AI-driven platform will redefine how clinical trials are designed and executed, with speed, accuracy, and new levels of insight that the industry urgently needs," said Dr. Ivarsson. "It's a privilege to join such an innovative, ambitious team driving a true paradigm shift in how we ...